Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers
作者
Mariana Araya de Godoy,Leonardo Martins Saraiva,Luiza Rachel Pinheiro de Carvalho,Andréia Vasconcelos-dos-Santos,Hellen J. V. Beiral,Alane Bernardo Ramos,Livian R. de Paula Silva,Renata B. Leal,Victor Hugo S. Monteiro,Carolina V. Braga,Carlla Assis Araújo-Silva,Leandro Cardoso Sinis,Victor Bodart‐Santos,Taís Hanae Kasai-Brunswick,Carolina de Lima Alcantara,Ana Paula C. A. Lima,Narcisa L. da Cunha-e Silva,Antônio Galina,Adalberto Ramón Vieyra,Fernanda G. De Felice
Alzheimer's disease (AD) is a disabling and highly prevalent neurodegenerative condition, for which there are no effective therapies. Soluble oligomers of the amyloid-β peptide (AβOs) are thought to be proximal neurotoxins involved in early neuronal oxidative stress and synapse damage, ultimately leading to neurodegeneration and memory impairment in AD. The aim of the current study was to evaluate the neuroprotective potential of mesenchymal stem cells (MSCs) against the deleterious impact of AβOs on hippocampal neurons. To this end, we established transwell cocultures of rat hippocampal neurons and MSCs. We show that MSCs and MSC-derived extracellular vesicles protect neurons against AβO-induced oxidative stress and synapse damage, revealed by loss of pre- and postsynaptic markers. Protection by MSCs entails three complementary mechanisms: 1) internalization and degradation of AβOs; 2) release of extracellular vesicles containing active catalase; and 3) selective secretion of interleukin-6, interleukin-10, and vascular endothelial growth factor to the medium. Results support the notion that MSCs may represent a promising alternative for cell-based therapies in AD.